Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	71223
Country	India

Received	2021-08-31 13:51
Peer-Review Started	2021-08-31 13:53
To Make the First Decision
Return for Revision	2021-11-17 08:17
Revised	2021-11-19 16:08
Second Decision	2022-05-11 03:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-05-12 20:10
Articles in Press	2022-05-12 20:10
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-04-27 17:08
Typeset the Manuscript	2022-05-16 00:26
Publish the Manuscript Online	2022-05-18 05:45

ISSN	2218-6220 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Letter to the Editor
Article Title	Self-monitoring of blood glucose in gestational diabetes mellitus patients during the COVID-19 pandemic in low- and middle-income countries
Manuscript Source	Unsolicited Manuscript
All Author List	Sumanta Saha
Funding Agency and Grant Number
Corresponding Author	Sumanta Saha, DNB, MBBS, Doctor, Teacher, Department of Community Medicine, R. G. Kar Medical College, 1, Kshudiram Bose Sarani, Kolkata 700004, West Bengal, India. sumanta.saha@uq.net.au
Key Words	COVID-19; Gestational diabetes; Blood glucose monitoring; Self-monitoring; Developing countries; Patient compliance
Core Tip	The barriers to self-monitoring of blood glucose (SMBG), one of the main treatment components in gestational diabetes mellitus (GDM), remain underexplored among women in low and middle-income countries during the ongoing coronavirus disease 2019 (COVID-19) pandemic when the emphasis is on telemedicine-based care. Based on the facts known in this context, plausible barriers to SMBG in GDM patients include: Poor internet connectivity, affordability of SMBG and digital applications to connect with healthcare providers, government-imposed lockdowns to decrease COVID-19 transmission, psychological stress, and mental health conditions. However, only definitive research will provide the correct answers.
Publish Date	2022-05-18 05:45
Citation	Saha S. Self-monitoring of blood glucose in gestational diabetes mellitus patients during the COVID-19 pandemic in low- and middle-income countries. World J Obstet Gynecol 2022; 11(2): 17-19
URL	https://www.wjgnet.com/2218-6220/full/v11/i2/17.htm
DOI	https://dx.doi.org/10.5317/wjog.v11.i2.17

Full Article (PDF)	WJOG-11-17.pdf
Full Article (Word)	WJOG-11-17.docx
Manuscript File	71223_Auto_Edited_LM.docx
Answering Reviewers	71223-Answering reviewers.pdf
Audio Core Tip	71223-Audio core tip.mp4
Conflict-of-Interest Disclosure Form	71223-Conflict-of-interest statement.pdf
Copyright License Agreement	71223-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	71223-Language certificate.pdf
Peer-review Report	71223-Peer-review(s).pdf
Scientific Misconduct Check	71223-Bing-Wang JJ-2.png
Scientific Editor Work List	71223-Scientific editor work list.pdf